https://www.avient.com/sites/default/files/resources/Gabelli%2520Conf%2520-%2520POL%2520IR%2520Presentation%2520wNon%2520GAAP%2520Reconciliation%252003%252026%252015.pdf
Platform operating income mix percentage
2005Y* 2008Y* 2010Y* 2013Y 2014Y
Global Color, Additives and Inks $ 4.3 $ 28.1 $ 37.7 $ 104.0 $ 124.9
Global Specialty Engineered Materials 0.4 17.6 49.7 57.2 72.4
Designed Structures and Solutions - - - 33.4 45.1
Specialty Platform $ 4.7 $ 45.7 $ 87.4 $ 194.6 $ 242.4
Performance Products and Solutions 75.7 31.3 54.0 56.0 63.1
Distribution 19.5 28.1 42.0 63.3 68.2
Joint ventures 91.9 28.6 18.9 - -
Corporate and eliminations (51.5) (425.1) (27.7) (82.4) (218.6)
Operating income (loss) GAAP $ 140.3 $ (291.4) $ 174.6 $ 231.5 $ 155.1
Less: Corporate operating expense 51.5 425.1 27.7 82.4 218.6
Operating income excluding Corporate $ 191.8 $ 133.7 $ 202.3 $ 313.9 $ 373.7
Specialty platform operating mix percentage 2% 34% 43% 62% 65%
* Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.
https://www.avient.com/sites/default/files/2020-10/investing-in-avient.pdf
D
is
t.
)
R
P
M
K
W
R
P
P
G
F
U
L
G
C
P
F
M
C
IF
F
H
X
L
H
U
N
F
O
E
E
M
N
E
C
L
S
C
L
K
R
A
A
S
H
C
E
G
R
A
A
L
B
As a specialty formulator, we don’t
require significant capital
investment, as compared to the
base resin raw material suppliers
we purchase from.
https://www.avient.com/sites/default/files/2021-05/avnt-first-quarter-2021-earnings-presentation.pdf
Develop and implement solutions to end plastic
waste while supporting AEPW $1.5B
investment in key initiatives.
2 0 3 0 S U STA I NA B I L I T Y TA RG E TS
15
PEER COMPARISONS
16
$442
$457
$560
2019PF 2020PF 2021E
$1.74
$1.93
$2.80
2019PF 2020PF 2021E
FULL YEAR 2019 – 2021 ORGANIC GROWTH
( T O TA L C O M PA N Y )
17
Sales Adjusted EBITDA
$3,981
$3,783
$4,300
2019PF 2020PF 2021E
+ 8%
Adjusted EPS
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
(1) (1)
(in millions) (in millions)
(1)(1)
+ 27% + 61%
(1) (1)
As a specialty formulator, we don’t
require significant capital
investment, as compared to the
base resin raw material suppliers
we purchase from.
https://www.avient.com/sites/default/files/2021-03/avient-march-ir-fermium_0.pdf
15
2 0 2 1 O U T L O O K
A S P R O V I D E D O N F E B R U A R Y 9 , 2 0 2 1
W E B C A S T
Synergies
($ millions)
Initial
Three-Year
Estimate
Revised
Three-Year
Estimate
2021
Expected
Realization
Administrative $ 18 $ 20 $ 15
Sourcing 24 30 15
Operational 18 25 5
Total Synergies $ 60 $ 75 $ 35
C L A R I A N T I N T E G R AT I O N &
C O S T S Y N ERG I E S U PDATE
17
• Integration going extremely well: synergy target increased from $60 million to $75 million
• $5 million of synergies in 2020 and expect to realize $35 million in 2021
• Relentless focus on guiding principles of safety first, employee collaboration and exceeding
customer expectations
• Future revenue synergies are not part of these estimates and represent additional growth over
the long term
$86
$103
2020PF 2021E
$0.53
$0.70
2020PF 2021E
ORGANIC GROWTH PROJECTIONS – Q1
( T O TA L C O M PA N Y )
18
Sales Adjusted Operating Income
$991
$1,090
2020PF 2021E
+ 10%
Adjusted EPS
+ 20% + 32%
(in millions) (in millions)
(1) (1) (1)
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
$308
$360
2020PF 2021E
$1.93
$2.40
2020PF 2021E
ORGANIC GROWTH PROJECTIONS – FULL YEAR
( T O TA L C O M PA N Y )
19
Sales Adjusted Operating Income
$3,783
$4,100
2020PF 2021E
+ 8%
Adjusted EPS
+ 17% + 24%
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
(1) (1)
(in millions) (in millions)
(1)
2020 Pro forma $3,783 $308
Sustainable Solutions 60 11% 24
Healthcare 60 11% 18
Composites 20 10% 10
Growth in Emerging Regions 50 7% 11
Other (GDP growth) 82 5% 11
Sub-total $4,055 7% $382
COVID Response Applications (25) - (11)
Outdoor High Performance Applications (15) - (7)
Asia Payroll Tax Subsidy (COVID) - - (4)
FX Impact 85 - 7
Synergies - - 30
Incentives, Travel, Other Employee Costs - - (37)
2021 Estimated $4,100 8% $360
2021 ORGANIC SALES AND OPERATING INCOME
( T O TA L C O M PA N Y )
20
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
(2) COVID Response Applications: facemasks, personal protective equipment
Sales Growth Rate
Adjusted
Operating
Income$ millions
(1)
(2)
C A S H F LOW A N D L E V E R AGE
21
• Asset light business generates
significant free cash flow
• Cash generation in 2021 partially offset
by restructuring activities to capture
synergies associated with the Clariant
Masterbatch acquisition
• Cash flow deployed to M&A,
opportunistic share repurchases and
balance sheet / leverage reduction
3.5x
2.7x
2.1x
2019PF 2020PF 2021E
Net Debt / Adjusted EBITDA
(1) (1)
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
($ millions) 2020 2021E
Adjusted EBITDA 382 510
Working Capital: Source / (Use) 116 (30)
Cash Taxes (40) (53)
Interest Paid (67) (76)
CapEx (62) (75)
CapEx for Synergy Capture (2) (20)
Restructuring for Synergy Capture (11) (25)
Other 22 19
Free Cash Flow 338 250
22
• 8% increase in sales drives 24% increase in adjusted EPS to $2.40
($2.70 excluding step-up depreciation and amortization) as a result of
continued growth in sustainable solutions and synergy capture
• Clariant synergy capture ahead of schedule: $35M of savings planned from
Clariant Masterbatch acquisition
• Adjusted EBITDA of $510M – highest level in company history
• Deleveraging ahead of schedule – 2.1x net debt to adjusted EBITDA by the
end of 2021
2021 PROJECTIONS
PEER COMPARISONS
23
As a specialty formulator, we don’t
require significant capital
investment, as compared to the
base resin raw material suppliers
we purchase from.
https://www.avient.com/sites/default/files/2020-11/investing-in-avient_0.pdf
PEER COMPARISONS
16
As a specialty formulator, we don’t
require significant capital
investment, as compared to the
base resin raw material suppliers
we purchase from.
https://www.avient.com/sites/default/files/2022-11/AVNT Q3 2022 Earnings Presentation - Website Final.pdf
Purchase price multiple rapidly declining on strength of
business and synergy capture
7
$133
$201
2019PF 2022E
7
Clariant Color EBITDA Growth
Purchase Price Multiple
10.8x
7.0x
6.4x
2019PF 2021 2022E w/ Full
Synergies
(1)
(1)
11.9%
16.3%
2019PF 2022E
EBITDA Margins
(1)
CLARIANT COLOR:
TRANSFORMATIONAL ACQUISITION
($ in millions)
(1) Financial information is pro forma to include a full year of Clariant Color business
SUNBELT PVC Resins DSS
20 Acquisitions
$4.8B Investment
$2.7B of Annual
Revenue
5 Divestments
$2.3B Proceeds
TPE
PP&S
HISTORI C SPECI AL IZATION THROUGH M& A
8
Distribution
DSM Protective
Materials
BOLT-ON AC QUI SITI ON HISTORY
9
Commercial
Resources
Operating Income
($ in millions)
Operating Margins
259
363
At Acquisition 2022E
$40
$139
At Acquisition 2022E
9%
22%
At Acquisition 2022E
Established Acquisitions
(> 7 years)
+ 40% + 248% + 1300 bps
I N V E S T T O G R O W
S P E C I A LT Y T R A N SF O R M ATI O N
T O D A Y
7%
46%
67%
86%
100%
0%
20%
40%
60%
80%
100%
2005 2010 2019 2021 2022 PF
%
o
f
A
d
ju
st
e
d
E
B
IT
D
A
• Commodity JVs
• Distribution
• Performance Products & Solutions
• Specialty Businesses
(1) Adjusted EBITDA is EBITDA excluding corporate costs and special items
(2) Pro forma for the acquisition of Dyneema® and divestiture of Distribution
(1
)
(2)
10
Healthcare
4%
Packaging
8%
Consumer
10%
Building &
Construction
43%
Industrial
15%
Transportation
14%
Energy
4%
Telecom.
2%
2006 2022 Pro Forma
Healthcare
8%
Packaging
23%
Consumer
21%
Building &
Construction
10%
Industrial
15%
Transportation
9%
Energy
4%
Telecom.
4%
Defense
6%
END MAR KET F OCUS ON LESS CYCL IC AL
I ND USTRI ES
11
14.8%
17.6%
21.0%
2018 2020 2022 PF
1.8%
2006
15.3%
16.2%
17.0%
2018PF 2020PF 2022E
CAI
2.7%
2006
SEM
SPEC IA LTY EBI TDA MA RGI N EX PANSION
12
• Portfolio transformation
accelerates growth in less
cyclical, higher margin end
markets
• Investments in our
composites platform
continue to drive margin
expansion
(1) (1)
(1) 2018 and 2020 financial information is pro forma to include a full year of Clariant Color acquisition
PORTFOLIO EVOLUTION OVER THE YEARS
13
Adj.
https://www.avient.com/sites/default/files/2022-03/AVNT Mar 2022 Presentation.pdf
FX)
2022 GROWTH PROJECTIONS
( T O TA L C O M PA N Y )
23
$3.05
$3.50
2021 2022E
Full Year – Adjusted EPS
+ 15%
(+ 17% excluding FX)
$0.89
$0.95
2021 2022E
Q1 – Adjusted EPS
+ 7%
(+ 10% excluding FX)
($ millions) Q1 Full Year Q1 Full Year
2021 - Actual 1,162$ 4,819$ 123$ 429$
Sustainable Solutions 27 110 12 44
Healthcare 15 66 4 13
Composites (excl.Outdoor High Performance) 11 29 5 13
Outdoor High Performance Applications (7) (20) (4) (10)
Growth in Asia / LATAM 10 51 3 11
Other 57 115 9 12
Sub-total 1,275$ 5,170$ 152$ 512$
Wage Inflation and Overtime (12) (18)
Other Supply Chain Costs (4) (7)
FX Impact (25) (70) (4) (8)
Synergies 4 15
Travel, Other Employee Costs (1) (4)
2022 - Estimated 1,250$ 5,100$ 135$ 490$
Sales
Adjusted
Operating Income
2022 SALES AND OI – Q1 AND FULL YEAR
( T O TA L C O M PA N Y )
24
($ millions) 2021 2022E
Cash Flow from Operating Activities 234$ 385$
Less:
Run-Rate CapEx (86) (90)
CapEx for Clariant Integration (15) (20)
CapEx for IT System Upgrade - (25)
Total CapEx (101) (135)
Free Cash Flow 133$ 250$
Adjusted EBITDA 581$ 635$
Net Debt / Adjusted EBITDA 2.2x 1.8x
25
C A SH F LOW / L E VE R AGE
26
• Record results – highest level of sales ($4.8B) and earnings
($3.05 adjusted EPS) in company history
• Successful Clariant Color integration – net debt to adjusted
EBITDA reduced to 2.2x, one-year ahead of schedule
• Recognized as one of America’s Most Responsible Companies
by Newsweek
• Earned 3rd consecutive Great Place to Work certification
2021 HIGHLIGHTS
27
• 15% adjusted EPS growth to $3.50, led by growth in sustainable
solutions and increased synergy realization
• Continued strong synergy capture from the Clariant Color integration:
$75M anticipated run-rate synergies by the end of 2022
• Adjusted EBITDA of $635M represents 9% growth above 2021 –
11% excluding the impact of foreign currencies
• Deleveraged to 1.8x net debt to adjusted EBITDA by the end of 2022
2022 SUMMARY
PEER COMPARISONS
29
As a specialty formulator, we don’t
require significant capital
investment, as compared to the
base resin raw material suppliers
we purchase from.
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520-%2520Investor%2520Day%25205-18-15.pdf
Garratt
Senior Vice President, President of
Performance Products & Solutions
John Midea
Senior Vice President,
Global Operations & Process
Improvement
Mark Crist
Senior Vice President, President of
PolyOne Distribution
Cathy Dodd
Vice President, Marketing
Chris Murphy
Vice President, Research & Development,
Chief Innovation Officer
Kurt Schuering
Vice President, Global Key Account
Management
The Leaders Behind the Team
PolyOne Corporation Page 8
Commodity to Specialty Transformation
• Volume driven,
commodity producer
• Heavily tied to
cyclical end markets
• Performance largely
dependent on non-
controlling joint
ventures
2000-2005 2006 - 2009 2010 – 2014 2015 and beyond
• Steve Newlin
appointed, Chairman,
President and CEO
• New leadership team
appointed
• Implementation of four
pillar strategy
• Focus on value based
selling, investment in
commercial resources
and innovation to drive
transformation
• Substantial EPS growth
from $0.13 to all-time
high of $1.80
• Shift to faster growing,
high margin, less
cyclical end markets
• Key acquisitions propel
current and future
growth, as well as
margin expansion
• Specialty mix expands
to 65% of Operating
Income – strongest mix
of earnings in history
• Accelerating growth
• Deliver consistent
double digit annual
EPS growth
• Maintain >35% vitality
index
• Pursue strategic
acquisitions that
expand specialty
offerings and
geographic breadth
• Invest and grow
current and next
generation talent
PolyOne Corporation Page 9
2006 2014
“Where we were” “Where we are”
Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 14.7%
Global Specialty Engineered Materials 1.1% 12.1%
Designed Structures & Solutions 1.4%(2012) 7.3%
Performance Products & Solutions 5.5% 7.7%
Distribution 2.6% 6.1%
Specialty Platform % of
Operating Income 6.0% 65%
ROIC 5.0% 11.3%
Adjusted EPS Growth N/A 37%
Proof of Performance
PolyOne Corporation Page 10
2%
34% 43%
62% 65%
0%
20%
40%
60%
80%
100%
2005 2008 2010 2013 2014
%
o
f O
pe
ra
tin
g
In
co
m
e*
JV's Performance Products & Solutions Distribution Specialty
Old
PolyOne
Mix Shift Highlights Specialty Transformation
New
PolyOne Transformation
Specialty OI $5M $46M $87M $195M $242M
*Operating Income excludes corporate charges and special items
PolyOne Corporation Page 11
2014 2015 Target
“Where we are” (Est. in 2012)
Operating Income %
Specialty:
Global Color, Additives & Inks 14.7% 12 – 16%
Global Specialty Engineered Materials 12.1% 12 – 16%
Designed Structures & Solutions 7.3% 8 – 10%
Performance Products & Solutions 7.7% 9 – 12%
Distribution 6.1% 6 – 7.5%
Specialty Platform % of
Operating Income 65% 65 – 75%
ROIC 11.3% 15%
Adjusted EPS Growth 37% Double Digit Expansion
Proof of Performance
PolyOne Corporation Page 12
• Sold non-core resin assets – EPS dilutive
• Completed acquisition of Spartech
• Housing starts below 1.25 million units
Single family units 30% below expectations
• Longstanding weakness in Europe, and
decline in Euro
Successfully Navigating Change Since 2012
PolyOne Corporation Page 13
-100%
0%
100%
200%
300%
400%
500%
600%
POL S&P 500
Strategy and Execution Drive Results
$0.12
$0.27
$0.21
$0.13
$0.68
$0.82
$1.00
$1.31
$1.80
'06 '07 '08 '09 '10 '11 '12 '13 '14
‘06-‘14 Adjusted EPS CAGR = 40%
Adjusted EPS Share Price vs.
Platform operating income mix
percentage 2005* 2006* 2007* 2008* 2009* 2010* 2011 2012 2013 2014
Global Color, Additives and Inks $ 4.3 $ 8.9 $ 25.7 $ 28.1 $ 25.2 $ 37.7 $ 50.2 $ 75.3 $104.0 $124.9
Global Specialty Engineered
Materials 0.4 3.9 4.9 17.6 20.6 49.7 45.9 47.0 57.2 72.4
Designed Structures and
Solutions - - - - - - - - 33.4 45.1
Specialty Platform $ 4.7 $ 12.8 $ 30.6 $ 45.7 $ 45.8 $ 87.4 $ 96.1 $122.3 $194.6 $242.4
Performance Products and
Solutions 75.7 64.2 65.8 31.3 33.1 54.0 27.7 38.8 56.0 63.1
Distribution 19.5 19.2 22.1 28.1 24.8 42.0 56.0 66.0 63.3 68.2
Joint ventures 91.9 102.9 34.8 28.6 25.5 18.9 5.0 - - -
Corporate and eliminations (51.5) 34.5 (73.3) (425.1) 7.9 (27.7) 18.2 (89.6) (82.4) (218.6)
Operating income (loss) GAAP $140.3 $ 233.6 $ 80.0 $(291.4) $137.1 $174.6 $203.0 $137.5 $231.5 $155.1
Less: Corporate operating
expense 51.5 (34.5) 73.3 425.1 (7.9) 27.7 (18.2) 89.6 82.4 218.6
Operating income excluding
Corporate $191.8 $199.1 $153.3 $133.7 $129.2 $202.3 $184.8 $227.1 $313.9 $373.7
Specialty platform operating mix
percentage 2% 6% 20% 34% 35% 43% 52% 54% 62% 65%
* Historical results have not been restated for the Resin business divestiture or the related resegmentation.
https://www.avient.com/sites/default/files/2022-02/AVNT Q4 2021 Earnings Presentation_0.pdf
FX)
2022 GROWTH PROJECTIONS
( T O TA L C O M PA N Y )
19
$3.05
$3.50
2021 2022E
Full Year – Adjusted EPS
+ 15%
(+ 17% excluding FX)
$0.89
$0.95
2021 2022E
Q1 – Adjusted EPS
+ 7%
(+ 10% excluding FX)
($ millions) Q1 Full Year Q1 Full Year
2021 - Actual 1,162$ 4,819$ 123$ 429$
Sustainable Solutions 27 110 12 44
Healthcare 15 66 4 13
Composites (excl.Outdoor High Performance) 11 29 5 13
Outdoor High Performance Applications (7) (20) (4) (10)
Growth in Asia / LATAM 10 51 3 11
Other 57 115 9 12
Sub-total 1,275$ 5,170$ 152$ 512$
Wage Inflation and Overtime (12) (18)
Other Supply Chain Costs (4) (7)
FX Impact (25) (70) (4) (8)
Synergies 4 15
Travel, Other Employee Costs (1) (4)
2022 - Estimated 1,250$ 5,100$ 135$ 490$
Sales
Adjusted
Operating Income
2022 SALES AND OI – Q1 AND FULL YEAR
( T O TA L C O M PA N Y )
20
($ millions) 2021 2022E
Cash Flow from Operating Activities 234$ 385$
Less:
Run-Rate CapEx (86) (90)
CapEx for Clariant Integration (15) (20)
CapEx for IT System Upgrade - (25)
Total CapEx (101) (135)
Free Cash Flow 133$ 250$
Adjusted EBITDA 581$ 635$
Net Debt / Adjusted EBITDA 2.2x 1.8x
21
C A SH F LOW / L E VE R AGE
22
• Record results – highest level of sales ($4.8B) and earnings
($3.05 adjusted EPS) in company history
• Successful Clariant Color integration – net debt to adjusted
EBITDA reduced to 2.2x, one-year ahead of schedule
• Recognized as one of America’s Most Responsible Companies
by Newsweek
• Earned 3rd consecutive Great Place to Work certification
2021 HIGHLIGHTS
23
• 15% adjusted EPS growth to $3.50, led by growth in sustainable
solutions and increased synergy realization
• Continued strong synergy capture from the Clariant Color integration:
$75M anticipated run-rate synergies by the end of 2022
• Adjusted EBITDA of $635M represents 9% growth above 2021 –
11% excluding the impact of foreign currencies
• Deleveraged to 1.8x net debt to adjusted EBITDA by the end of 2022
2022 SUMMARY
PEER COMPARISONS
25
As a specialty formulator, we don’t
require significant capital
investment, as compared to the
base resin raw material suppliers
we purchase from.
https://www.avient.com/sites/default/files/2021-02/avient-ir-presentation-goldman-sachs-and-morgan-stanley.pdf
16
2 0 2 1 O U T L O O K
Synergies
($ millions)
Initial
Three-Year
Estimate
Revised
Three-Year
Estimate
2021
Expected
Realization
Administrative $ 18 $ 20 $ 15
Sourcing 24 30 15
Operational 18 25 5
Total Synergies $ 60 $ 75 $ 35
C L A R I A N T I N T E G R AT I O N &
C O S T S Y N ERG I E S U PDATE
18
• Integration going extremely well: synergy target increased from $60 million to $75 million
• $5 million of synergies in 2020 and expect to realize $35 million in 2021
• Relentless focus on guiding principles of safety first, employee collaboration and exceeding
customer expectations
• Future revenue synergies are not part of these estimates and represent additional growth over
the long term
$86
$103
2020PF 2021E
$0.53
$0.70
2020PF 2021E
ORGANIC GROWTH PROJECTIONS – Q1
( T O TA L C O M PA N Y )
19
Sales Adjusted Operating Income
$991
$1,090
2020PF 2021E
+ 10%
Adjusted EPS
+ 20% + 32%
(in millions) (in millions)
(1) (1) (1)
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
$308
$360
2020PF 2021E
$1.93
$2.40
2020PF 2021E
ORGANIC GROWTH PROJECTIONS – FULL YEAR
( T O TA L C O M PA N Y )
20
Sales Adjusted Operating Income
$3,783
$4,100
2020PF 2021E
+ 8%
Adjusted EPS
+ 17% + 24%
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
(1) (1)
(in millions) (in millions)
(1)
2020 Pro forma $3,783 $308
Sustainable Solutions 60 11% 24
Healthcare 60 11% 18
Composites 20 10% 10
Growth in Emerging Regions 50 7% 11
Other (GDP growth) 82 5% 11
Sub-total $4,055 7% $382
COVID Response Applications (25) - (11)
Outdoor High Performance Applications (15) - (7)
Asia Payroll Tax Subsidy (COVID) - - (4)
FX Impact 85 - 7
Synergies - - 30
Incentives, Travel, Other Employee Costs - - (37)
2021 Estimated $4,100 8% $360
2021 ORGANIC SALES AND OPERATING INCOME
( T O TA L C O M PA N Y )
21
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
(2) COVID Response Applications: facemasks, personal protective equipment
Sales Growth Rate
Adjusted
Operating
Income$ millions
(1)
(2)
C A S H F LOW A N D L E V E R AGE
22
• Asset light business generates
significant free cash flow
• Cash generation in 2021 partially offset
by restructuring activities to capture
synergies associated with the Clariant
Masterbatch acquisition
• Cash flow deployed to M&A,
opportunistic share repurchases and
balance sheet / leverage reduction
3.5x
2.7x
2.1x
2019PF 2020PF 2021E
Net Debt / Adjusted EBITDA
(1) (1)
(1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition
($ millions) 2020 2021E
Adjusted EBITDA 382 510
Working Capital: Source / (Use) 116 (30)
Cash Taxes (40) (53)
Interest Paid (67) (76)
CapEx (62) (75)
CapEx for Synergy Capture (2) (20)
Restructuring for Synergy Capture (11) (25)
Other 22 19
Free Cash Flow 338 250
23
• 8% increase in sales drives 24% increase in adjusted EPS to $2.40
($2.70 excluding step-up depreciation and amortization) as a result of
continued growth in sustainable solutions and synergy capture
• Clariant synergy capture ahead of schedule: $35M of savings planned from
Clariant Masterbatch acquisition
• Adjusted EBITDA of $510M – highest level in company history
• Deleveraging ahead of schedule – 2.1x net debt to adjusted EBITDA by the
end of 2021
2021 PROJECTIONS
PEER COMPARISONS
24
As a specialty formulator, we don’t
require significant capital
investment, as compared to the
base resin raw material suppliers
we purchase from.